OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Contraception and Reproductive Health Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
A pioneer of hormonal contraception: Joseph W. Goldzieher	137
Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999–2015 Zimbabwe Demographic Health Survey	45
Correction	37
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]	20
Family planning and contraception in women of reproductive age with systemic lupus erythematosus: a narrative review	18
How often is oral contraception used for contraception? The need of benefit’s formalisation	17
Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort	15
Hypertension and smoking as contraindications to combined hormonal contraception but not to postmenopausal hormone therapy: but natural oestrogens (oestradiol and estetrol) are the same!	15
The prolonged-release oral formulations: a new era in hormonal contraception technology?	14
Investigating barriers to effective contraceptive use in Sub-Saharan Africa and addressing associated challenges	14
Effect of antenatal contraceptive education and other factors on uptake of long-acting reversible contraception in postpartum women in Hong Kong	13
Contraceptive switch and abandonment among women using the pill, condoms and injectables in Brazil	12
Migration and newborn screening: time to build on the European Asylum, Integration and Migration Fund?	12
The far-reaching impact of abortion bans: reproductive care and beyond	10
Knowledge of contraceptive methods among deaf women: a qualitative study	9
Perception of oral contraception – do women think differently from gynaecologists?	9
Factors affecting age at menopause and their relationship with ovarian reserve: a comprehensive review	8
Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks’ gestation: a case series and systematic review of the literature	8
Improving access to postpartum contraception – a review of global guidelines with ESCRH consensus recommendations for Europe	8
The preferences of women in Australia for the features of long-acting reversible contraception: results of a discrete choice experiment	7
Women’s decision-making related to induced abortion – a cross sectional study during a period of Covid-19 pandemic, in Sweden	7
Statement of Retraction [Can Porphyromonas gingivalis be a novel aetiology for recurrent miscarriage?]	7
Asked but not received: postpartum contraception access in opioid-using pregnant patients	7
Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure ^® implant removal: a cross-sectional study	7
Improvement of laboratory markers of anaemia in the treatment of heavy menstrual bleeding with a 19.5-mg intrauterine device: a pilot study	7

Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods	6
Statement of Retraction [Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial]	6
Optimising contraceptive counselling: insights for obesity and bariatric surgery patients	6
The criminalisation of women’s healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes	6
“Better late than never but never late is better”, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis	6
Sequential treatment with relugolix combination therapy in women with symptomatic uterine fibroids that were inadequately managed with 52 mg levonorgestrel intrauterine system: the first report	6
Experiences and impacts of side effects among contraceptive users in the UK: exploring individual narratives of contraceptive side effects	5
Advancing access, evidence, and equity in abortion care	5
The pre- Roe legal framework: a dissecting study of the evolution of abortion laws and their socio-legal implications	5
Does change in the shape of intrauterine contraceptive device Cu 375 and Cu T 380A affect the expulsion after post-partum insertion – a prospective randomized control trial	5
The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain	5
Narratives of men and women from the southeastern region of Brazil on some aspects of sexual and reproductive health, sexual life and contraception: a qualitative study	5
Retraction Notice	5
Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder	5
Access to abortion in a cross-border region in the Eastern Pyrenees: the case of Hospital de Cerdanya, between Spanish and French legislation	4
Pharmacist recommendations for emergency contraception in Belgium: a simulated user study	4
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age – a systematic review	4
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic	4
Ulipristal acetate for medical abortion: did we really need to create a ‘monster’?	4
Clinical improvement after Essure® devices removal: a systematic review	4
Retraction	4
We don´t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!	4
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction	4
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition	4
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women	4
Usage of postpartum intrauterine contraceptive device (postpartum-IUD) after an increase in the institutional delivery rate in India: time to re-visit the effect of timing of counselling on its accept	4
A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion	4
Impact of abortion bans on pregnancies with severe life-limiting foetal anomalies in the United States: a cost-effectiveness analysis	4
Statement of Retraction: “Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users	4
Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives	4
Contraception for adolescent and young women. A consensus conference results	4
Onset and recovery from depressive mood changes on progestin treatment - a case series reporting the course and type of depressive symptoms in progestin users with different histories and risks	4
Editors’ response	3
Real-world satisfaction and menstrual bleeding pattern with available LNG-IUD among Spanish young women	3
Intrauterine devices and gynaecological malignancies - an umbrella review of systematic reviews and meta-analyses	3
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review	3
From hesitancy to hope: charting India’s path to widespread HPV immunisation	3
‘Do I want children later in life?’ Reproductive intentions of 1700 adolescents	3
Depomedroxyprogesterone acetate impact on mifepristone action during medication abortion	3
From request to dispensation: how adolescent and young adult females experience access to emergency contraception in pharmacies	3
Expression of Concern	3
A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns	3
Contraception among HIV-positive women in Latvia- knowledge, experience and factors influencing the choice	3
Fertility awareness, reproductive autonomy and what people should know about having children	3
Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients	3
Comments on: ‘Critical assessment of a prolonged-release EE/DNG contraceptive safety analysis’ - a letter to the editor to the European Jornal of Contraception by Jonathan Douxfils et al	3
Can transvaginal cervical length and cervical strain elastography predict mid-trimester medical induction to abortion intervals?	3
Knowledge, professional attitudes, and training among health professionals regarding male contraceptive methods	3
High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy	3
Authors response to article retraction	3

Oral hormonal therapy as treatment option for abnormal uterine bleeding	3
Correction	3
Views, attitudes and experiences of South Asian women concerning sexual health services in the UK: a qualitative study	3
Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours	3
Legal abortion requests and outcomes for women when the law is restrictive – experience from a referral centre in south-eastern Brazil	3
Medical termination of pregnancy: people’s expectations and experiences in the Netherlands	3